Sebelipase alfa is a recombinant form of the enzyme lysosomal acid lipase that was approved in 2015 under the tradename Kanuma in the US and EU for the treatment of people with lysosomal acid lipase deficiency.
Sebelipase alfa is a recombinant form of the enzyme lysosomal acid lipase that was approved in 2015 under the tradename Kanuma in the US and EU for the treatment of people with lysosomal acid lipase deficiency.
Sebelipase alfa is a recombinant form of the enzyme lysosomal acid lipase that was approved in 2015 under the tradename Kanuma in the US and EU for the treatment of people with lysosomal acid lipase deficiency.
ThingsTodoPost © 2018 - 2024 All rights reserved.